Counterpoint Mutual Funds’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.7M Buy
32,947
+9,870
+43% +$3.17M 1.01% 5
2026
Q2
$11.1M Sell
23,077
-20,020
-46% -$5.31M 1.1% 6
2026
Q1
$4.72M Buy
+43,097
New +$6.14M 0.71% 31
2025
Q4
– Sell
-2,471
Closed -$484K – 510
2025
Q3
$484K Buy
+2,471
New +$406K 0.04% 174

Other funds holding ALAB

Counterpoint Mutual Funds's ALAB Position: Q3 2026 in Review

Counterpoint Mutual Funds increased its Astera Labs (ALAB) stake by 43% in Q3 2026, buying an estimated $3.17M and bringing the position to 32,947 shares worth $11.7M. The position accounts for 1.01% of the portfolio, ranked #5.

Counterpoint Mutual Funds first reported a position in ALAB in Q3 2025 and has held it in 4 quarters since. 132 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Counterpoint Mutual Funds held 32,947 shares of Astera Labs worth $11.7M as of Q3 2026.
  • Counterpoint Mutual Funds bought 9,870 Astera Labs shares in Q3 2026, an estimated $3.17M.
  • Astera Labs made up 1.01% of Counterpoint Mutual Funds's portfolio in Q3 2026, its #5 holding.
  • Counterpoint Mutual Funds first reported a position in Astera Labs in Q3 2025 and has held it in 4 quarters since.
  • 132 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2026, filed 16 Oct 2026.